Cambridge Investment Research Advisors
CRVO icon

Cambridge Investment Research Advisors’s CervoMed CRVO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-277
Closed -$6K – 3187
2021
Q4 		$6K Hold
277
– – ﹤0.01% 3158
2021
Q3 		$11K Hold
277
– – ﹤0.01% 3071
2021
Q2 		$15K Buy
+277
New +$15.3K ﹤0.01% 3071
2021
Q1 		– Sell
-277
Closed -$17K – 2887
2020
Q4 		$17K Hold
277
– – ﹤0.01% 2691
2020
Q3 		$18K Buy
277
+90
+48% +$6.84K ﹤0.01% 2494
2020
Q2 		$14K Buy
+187
New +$11.4K ﹤0.01% 2441

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cambridge Investment Research Advisors's CRVO Position: Q1 2022 in Review

Cambridge Investment Research Advisors sold out of CervoMed (CRVO) in Q1 2022, closing a stake of 277 shares — an estimated $6K sold.

Cambridge Investment Research Advisors first reported a position in CRVO in Q2 2020 and held it in 6 quarters. The position peaked at $18K in Q3 2020. 19 funds tracked by Wall St. Rank hold CRVO as of Q1 2022.

  • Cambridge Investment Research Advisors reported no remaining CervoMed position as of Q1 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 277 CervoMed shares in Q1 2022, an estimated $6K.
  • Cambridge Investment Research Advisors first reported a position in CervoMed in Q2 2020 and held it in 6 quarters.
  • Cambridge Investment Research Advisors's CervoMed position peaked at $18K in Q3 2020.
  • 19 funds tracked by Wall St. Rank held CervoMed as of Q1 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2022, filed 12 May 2022.